RIP-qPCR Service for Targeted RNA–Protein Interaction Validation
RIP-qPCR (RNA immunoprecipitation qPCR) is a targeted assay that combines RNA immunoprecipitation with quantitative RT-PCR to confirm specific RNA–protein interactions in cells or tissues. CD Genomics provides an end-to-end RIP-qPCR service, from experimental design and antibody selection to qPCR data analysis and reporting, strictly for research use only.
- Validated RIP-qPCR workflow reduces RNA degradation and non-specific binding, so you obtain reproducible fold-enrichment values for your RNA-binding protein targets.
- Integrated RNA immunoprecipitation qPCR service removes protocol optimization and troubleshooting from your team, so you move from candidate lists to validated RNA–protein interactions in less time.
- Commercial RIP kits with IgG and input controls lower experimental failure rates and background noise, so you can make confident claims about post-transcriptional regulation and RNA epigenetic mechanisms.
What Is RIP-qPCR
RIP-qPCR (RNA immunoprecipitation qPCR) is a targeted assay used to confirm RNA–protein interactions in living cells or tissues. It combines RNA immunoprecipitation (RIP) with quantitative RT-PCR to measure how strongly a specific protein or RNA modification is enriched on defined transcripts, instead of just tracking global RNA levels.
In a RIP-qPCR experiment, an antibody captures an RNA-binding protein or a modification-marked RNA together with its bound RNAs. After RNA purification and reverse transcription, qPCR quantifies each candidate transcript in the RIP fraction relative to IgG and input controls. This focused, quantitative readout makes RIP-qPCR a natural follow-up to discovery methods such as RIP-seq or CLIP-seq when you need to confirm and prioritise key interactions.
By providing gene-level enrichment data, RIP-qPCR helps separate genuine binding events from simple expression changes. The resulting profiles give you clearer insight into post-transcriptional regulation and RNA epigenetics and can be used directly in figures, models, and reviewer responses.
How Does RIP-qPCR Work?
RIP-qPCR follows a controlled workflow that preserves native RNA–protein complexes and produces reliable fold-enrichment values.
- Cell or tissue lysis
Cells or tissues are gently lysed in RNase-free buffer to release intact RNA–protein complexes while limiting RNA fragmentation.
- RNA immunoprecipitation (RIP)
A specific antibody against the target RNA-binding protein or RNA modification is added with Protein A/G beads. An IgG control is processed in parallel to capture non-specific background.
- Protein digestion and RNA purification
After washing away unbound components, proteins are digested and co-precipitated RNA is purified using column- or reagent-based methods under RNase-free conditions.
- cDNA synthesis
RNA from RIP, IgG, and input fractions is converted into cDNA by reverse transcription using standardised protocols.
- Quantitative RT-qPCR
qPCR assays for each candidate RNA are run across all fractions. The resulting Ct values are used to calculate relative enrichment and fold changes within and between conditions.
This stepwise RIP-qPCR protocol is optimized specifically for RNA–protein interaction analysis, helping to minimise non-specific binding and RNA degradation. In practice, this yields consistent enrichment patterns that can be compared across replicates, time points, and experimental groups.
When to Use RIP-qPCR: Applications in RNA Biology and RNA Epigenetics
You should consider RIP-qPCR when you already have candidate RNAs or proteins and need clear, quantitative evidence of their interactions. Instead of running another broad sequencing screen, RIP-qPCR lets you test a focused set of transcripts in defined biological contexts, especially in RNA biology and RNA epigenetics studies.
Validating Candidates from RIP-seq, CLIP-seq, and RNA Pull-Down
Transcriptome-wide methods such as RIP-seq, CLIP-seq, and RNA pull-down often produce long lists of potential binding targets. RIP-qPCR helps you decide which of these interactions are truly robust.
- Design qPCR assays around priority candidates from sequencing or pull-down datasets.
- Measure enrichment as fold change in RIP versus IgG or input fractions.
- Select a smaller panel of strongly supported interactions for figures and functional follow-up.
This targeted validation step turns discovery data into concise, gene-level evidence that reviewers and project teams can interpret quickly.
Probing RNA Epigenetic Marks (m6A, ac4C, and Others)
In RNA epigenetics, RIP-qPCR is a practical way to study how modifications such as m6A and ac4C affect specific transcripts.
- Use antibodies against RNA marks or reader proteins to enrich modified RNAs.
- Test whether defined mRNAs, lncRNAs, or viral RNAs carry a given modification.
- Compare modification-associated enrichment between conditions, cell types, or disease states.
These experiments are particularly relevant in immune regulation, antiviral immunity, and cancer models, where subtle changes in RNA modification can reshape pathway activity.
Comparing Conditions, Genotypes, and Treatments
RIP-qPCR is well suited to comparative designs where interaction strength may change across conditions.
- Quantify binding differences between wild-type and knockout or mutant models.
- Assess the impact of drugs, biologics, or environmental stimuli on RNA–protein interactions.
- Track interaction dynamics over time in activation, stress, or differentiation studies.
This type of analysis supports mode-of-action work and target validation in translational and drug discovery programs.
Investigating Noncoding and Viral RNA Mechanisms
RIP-qPCR can be extended beyond mRNA to cover a broad range of RNA species, which is important in complex regulatory systems.
- Develop qPCR assays for long noncoding RNAs, circular RNAs, or viral genomes and transcripts.
- Examine how a single protein or RNA modification engages multiple RNA classes within one workflow.
- Build integrated models that include coding, noncoding, and pathogen-derived RNAs.
For infection biology, oncology, and systems-level RNA studies, this broader view offers more realistic insight than focusing on mRNA alone.
RIP-qPCR vs RIP-seq and Other RNA–Protein Interaction Methods
RIP-qPCR is one of several options for studying RNA–protein interactions. It is most useful when you already know which transcripts you care about and need focused, quantitative validation rather than another discovery-scale experiment.
Method Comparison at a Glance
| Method | Main Question | Scale | Typical Output | Best Used For |
|---|---|---|---|---|
| RIP-qPCR | Does this protein/modification bind these specific RNAs? | Targeted (tens of genes) | Ct values, fold enrichment for selected transcripts | Validating candidates, comparing conditions, mechanism panels |
| RIP-seq | Which RNAs are associated with this protein? | Genome-wide | Enriched transcript lists, peak profiles | Discovery of binding targets and pathways |
| CLIP-seq (and variants) | Where on the RNA does the protein bind? | Genome-wide, nucleotide-level | Crosslink sites, binding maps | High-resolution binding site mapping |
| RNA pull-down | Which proteins bind this specific RNA or RNA motif? | Proteome-level | Protein ID lists (often by MS) | Discovering protein partners of one RNA |
How to Choose in Practice
- Choose RIP-qPCR when you have a shortlist of RNAs and need robust, gene-level enrichment data for figures or decision-making.
- Choose RIP-seq or CLIP-seq when you want to discover new targets or map binding on a global scale.
- Combine RIP-seq → RIP-qPCR when you want a discovery phase followed by targeted validation on key hits.
- Use RNA pull-down when your primary question is "which proteins bind this RNA?", rather than "which RNAs bind this protein?".
In many projects, RIP-qPCR sits at the validation and mechanism stage, complementing earlier sequencing-based screens rather than replacing them.
RIP-qPCR Service Advantages with CD Genomics
Choosing a RIP-qPCR service means trusting a partner with both your samples and your hypotheses. CD Genomics is set up to support projects that move from broad RNA–protein interaction discovery to focused, quantitative validation, without adding extra work to your team.
End-to-End RIP-qPCR Workflow
We handle the full RNA immunoprecipitation qPCR workflow, from design to data. You provide cells or tissue and your target list; we take care of buffer selection, RIP conditions, qPCR setup, and analysis.
- Support from project scoping through to final report.
- One coordinated workflow instead of multiple vendors or in-house handoffs.
- Reduced need for in-lab optimization, saving time and staff effort.
This helps you move faster from candidate interactions to validated results that can go into figures and decision decks.
Optimized RIP Protocols with Commercial Kits and Proper Controls
RIP experiments are sensitive to antibodies, lysis conditions, and wash steps. To stabilise performance, we use commercial RIP kits and standardised protocols where possible, then adapt them to your system only as needed.
- Validated reagents and RNase-free conditions to protect RNA–protein complexes.
- Built-in IgG negative controls and input fractions to monitor background.
- Consistent handling across samples to support fair comparisons.
These design choices help lower the risk of failed pulls or misleading enrichment caused by non-specific binding.
Quantitative, Publication-Ready RIP-qPCR Data
RIP-qPCR is only useful if the final data are easy to interpret and share. Our reporting focuses on clear, quantitative summaries suited to manuscripts, presentations, and internal reviews.
- Ct tables for RIP, IgG, and input samples for each target.
- Fold enrichment values and group comparisons presented in simple tables and plots.
- Amplification and melting curves available for specificity checks.
You receive a dataset that can be dropped directly into your own analysis pipeline or converted into figure panels with minimal editing.
Study Design and Assay Support from RNA–Protein Specialists
Good RIP-qPCR starts with good design. Our scientists work with you to align antibody choice, target selection, and replicates with your research questions.
- Guidance on choosing target RBPs or RNA modifications for RIP.
- Primer design support for mRNA, lncRNA, circRNA, or viral RNA targets.
- Practical advice on biological replicates and controls for publication or regulatory requirements.
This reduces the risk of redesigning experiments mid-project and helps ensure that your RIP-qPCR service run answers the questions you actually care about.
RIP-qPCR Workflow at CD Genomics
Our RIP-qPCR workflow is built as a straightforward service pipeline. You send us cells or tissue with your questions and target list; we handle the lab work and data processing under standardised, research-use-only conditions.
1. Project Consultation and Assay Design
We start with a short technical discussion to align the experiment with your goals. Together we define the RNA-binding protein or modification, select target and control transcripts, and agree on species, sample types, and biological replicates.
2. Sample Receipt and Initial QC
When your samples arrive, we log and verify them, checking identity, amount, and storage conditions. If needed, we perform small pilot checks to confirm that the material is suitable for RIP-qPCR before proceeding.
3. RIP Experiment (Lysis and Immunoprecipitation)
We perform gentle lysis and RNA immunoprecipitation using optimized buffers, commercial RIP reagents, and your chosen antibody, with IgG and input processed in parallel. The focus is to preserve native RNA–protein complexes while keeping background low and conditions consistent across all samples.
4. RNA Purification and cDNA Preparation
After immunoprecipitation, we purify RNA from RIP, IgG, and input fractions and convert it into cDNA using standardised reverse transcription protocols. This provides clean, comparable templates for downstream qPCR.
5. Quantitative RT-qPCR
We run qPCR assays for your selected targets and controls with technical replicates across all fractions. The resulting Ct values form the quantitative backbone for calculating enrichment and comparing conditions.
6. Data Analysis and Reporting
Finally, we transform raw qPCR outputs into interpretable RIP-qPCR results. You receive Ct tables, fold-enrichment summaries, and key plots, along with concise methods and QC notes, plus the option to discuss the data with our scientists for interpretation and next-step planning.
Note: Detailed protocol-level steps (lysis, IP, purification, cDNA, qPCR) are described conceptually in the earlier "How Does RIP-qPCR Work?" section; here the emphasis is on how CD Genomics organises and manages the service around your project.
RIP-qPCR Data Analysis
RIP-qPCR data analysis turns raw Ct values into quantitative measures of RNA–protein interaction strength. At CD Genomics, we use a standardised pipeline to check assay quality, apply appropriate normalisation, and summarise enrichment so you can compare genes and conditions with confidence.
- Review Ct values from RIP, IgG, and input fractions to identify failed reactions or outliers.
- Inspect amplification and melting curves to confirm specificity and acceptable efficiency.
Only data that pass these checks are used for downstream enrichment calculations.
Normalisation and Fold-Enrichment Calculation
- Normalise Ct values using reference targets or input fractions according to your study design.
- Calculate enrichment for each transcript relative to IgG and/or input (e.g. RIP/Input, RIP/IgG), using ΔCt or ΔΔCt where needed.
This expresses binding as fold enrichment, making it clear which RNAs are truly associated with the target protein or modification.
Comparative Analysis and Summaries
- Aggregate enrichment values across biological replicates and report means and variability.
- Highlight differences between conditions (for example, wild-type vs knockout or treated vs untreated) in tables and simple plots.
- Provide concise tables, plots, and notes so you can move directly from raw measurements to interpretable quantitative conclusions.
These outputs give you a transparent link from qPCR data to interaction profiles that are ready for figures, internal reviews, or follow-up experiments.
RIP-qPCR Deliverables and Demo Outputs
You receive a compact, ready-to-use data package at the end of each RIP-qPCR project.
- Data tables: raw Ct values for RIP, IgG, and input, plus processed fold-enrichment results with replicate summaries.
- Figures: simple plots of fold enrichment across conditions that can be adapted for manuscripts or slides.
- Documentation: a short methods and QC note explaining how data were generated and checked.
Example RIP-qPCR Ct values for a target gene.
RIP-qPCR amplification plot showing multiple qPCR fluorescence curves and Ct points across PCR cycles
RIP-qPCR melt curve confirming assay specificity
RIP-qPCR Sample Requirements
| Sample Type | Recommended Minimum Input per Condition | Notes |
|---|---|---|
| Cultured cells | ≥ 5 × 10⁸ cells | Adherent or suspension cell lines or primary cells |
| Tissue (fresh-frozen) | ≥ 500 mg | Animal or human research tissue |
| Other (e.g. organoids, special samples) | Case by case | Please contact us for feasibility |
Storage and Shipping Guidelines
- Prepare samples under RNase-free conditions where possible.
- Snap-freeze cell pellets or tissue pieces in liquid nitrogen.
- Store at –80 °C until shipment; avoid repeated freeze–thaw cycles.
- Use securely sealed, clearly labelled 1.5–2 mL tubes with secondary containment.
- Ship on dry ice via overnight or priority courier.
- Include a simple sample list or manifest so we can match tubes to your project design.
Experimental Design and Controls for RIP-qPCR
Sound RIP-qPCR data starts with a simple but well-planned design. We help you set up basic controls, replicates, and primers so enrichment values are easy to interpret.
Key Controls
- IgG control IP: monitors non-specific binding.
- Input fraction: reflects total RNA level for each sample.
- Non-target genes: confirm that non-specific transcripts are not enriched.
These controls separate true RNA–protein interactions from background and expression changes.
Replicates
- Biological replicates: typically 2–3 per condition.
- Technical qPCR replicates: 2–3 per target to stabilise Ct values.
Processing all conditions in parallel helps reduce batch effects.
Primer and Target Basics
- Short amplicons (around 70–150 bp) with good efficiency.
- Exon–exon spanning primers for mRNAs where possible.
- Optional reference genes if normalisation to expression is required.
We can support primer and target selection for mRNA, lncRNA, circRNA, and viral RNA according to your study goals.
Case Study
RIP-qPCR FAQ
References
- Amin, H.M., Szabo, B., Abukhairan, R. et al. In Vivo and In Vitro Characterization of the RNA Binding Capacity of SETD1A (KMT2F). International Journal of Molecular Sciences 24, 16032 (2023).
- Gagliardi, M., Matarazzo, M.R. RIP: RNA Immunoprecipitation. Methods in Molecular Biology 1480, 73–86 (2016).
- Baker, M., Khosravi, R., Salton, M. Native RNA Immunoprecipitation (RIP) for Precise Detection and Quantification of Protein-Interacting RNA. Methods in Molecular Biology 2666, 107–114 (2023).
- Sun, L., Li, X., Xu, F. et al. A critical role of N⁴-acetylation of cytidine in mRNA by NAT10 in T cell expansion and antiviral immunity. Nature Immunology 26, 619–634 (2025).
- Zhang, S., Liu, Y., Ma, X. et al. Recent advances in the potential role of RNA N⁴-acetylcytidine in cancer progression. Cell Communication and Signaling 22, 49 (2024).